Efficacy and safety of sacubitril/valsartan vs. valsartan in patients with acute myocardial infarction: A meta-analysis

BACKGROUND: The angiotensin-receptor neprilysin inhibitor (ARNI) sacubitril/valsartan was shown to be superior to the angiotensin receptor blocker (ARB) valsartan in terms of reversing heart failure classification (NYHA classification), reducing N-terminal pro-brain natriuretic peptide (NT-proBNP) l...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Pei, Han, Yang, Lian, Cheng, Wu, Xinlei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448932/
https://www.ncbi.nlm.nih.gov/pubmed/36093128
http://dx.doi.org/10.3389/fcvm.2022.988117

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448932/
https://www.ncbi.nlm.nih.gov/pubmed/36093128
http://dx.doi.org/10.3389/fcvm.2022.988117

Ejemplares similares